Cigna Group (CI) Stock Analysis
Verdict: WATCH (do not buy)
Robust Evernorth cash generation and ~11.5x P/E margin offset regulatory PBM headwinds and recent analyst rating downgrades.
Investment score: 60/100
Analysis as of
Is Cigna Group stock worth reviewing? AI model thesis
The AI model rates Cigna Group as a Hold. Exceptional cash flow ($8.39B FCF) and cheap valuation (11.69x P/E) are balanced by political regulatory risks surrounding pharmacy benefit management (PBM) and cooling Wall Street sentiment.
7-factor investment score
- Valuation: 72/100 (weight 20%)
- Financial Health: 65/100 (weight 15%)
- Technical Momentum: 52/100 (weight 15%)
- Earnings Quality: 60/100 (weight 15%)
- Insider Sentiment: 35/100 (weight 10%)
- Analyst Consensus: 55/100 (weight 10%)
- Risk-Adjusted Return: 70/100 (weight 15%)
Cigna Group opportunities and risks
What speaks for CI
- Aggressive Share Buyback Accretion
What speaks against CI
- Legislative and Regulatory PBM Reform
Frequently asked questions about Cigna Group (CI)
Is CI stock a good investment?
The cached TradeMates AI model rates Cigna Group as WATCH (do not buy) with an investment score of 60/100. The AI model rates Cigna Group as a Hold. Exceptional cash flow ($8.39B FCF) and cheap valuation (11.69x P/E) are balanced by political regulatory risks surrounding pharmacy benefit management (PBM) and cooling Wall Street sentiment. This is algorithmic model output, not personal investment advice.
Is CI stock a buy?
The TradeMates model verdict for CI is WATCH (do not buy) with an investment score of 60/100. Treat this as a model signal to review, not a personal buy recommendation.